Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis - Tran, William T; Gangeh, Mehrdad J; Sannachi, Lakshmanan; Chin, Lee; Watkins, Elyse; Bruni, Silvio G; Rastegar, Rashin Fallah; Curpen, Belinda; Trudeau, Maureen; Gandhi, Sonal; Yaffe, Martin; Slodkowska, Elzbieta; et al. (British journal of cancer, 2017)
Keywords: 631/1647/527; 692/53/2423; 692/699/67/1059/99; 692/699/67/1347; Accuracy; Anthracyclines - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Area Under Curve; Biomedical and Life Sciences; Biomedicine; Breast cancer; Breast Neoplasms - diagnostic imaging; Breast Neoplasms - drug therapy; Breast Neoplasms - pathology; Bridged-Ring Compounds - administration & dosage; Cancer Research; Cancer therapies; Carcinoma, Ductal, Breast - diagnostic imaging; Carcinoma, Ductal, Breast - drug therapy; Carcinoma, Ductal, Breast - pathology; Carcinoma, Lobular - drug therapy; Carcinoma, Lobular - pathology; Chemotherapy; Chemotherapy, Adjuvant; Drug Resistance; Epidemiology; Female; Health sciences; Hemoglobin; Hemoglobins - metabolism; Humans; Magnetic resonance imaging; Mammography; Medical imaging; Medical research; Middle Aged; Molecular Medicine; Neoadjuvant Therapy; Oncology; Oxygen - metabolism; Predictive Value of Tests; Radiation; ROC Curve; Spectrum Analysis; Taxoids - administration & dosage; Tomography, Optical - methods; Translational Therapeutics; Trastuzumab - administration & dosage; Tumor Burden; Tumors; United Kingdom--UK; Toronto Ontario Canada; Canada; imaging biomarkers; diffuse optical spectroscopy imaging; breast cancer